These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25884309)

  • 1. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.
    Matsubara J; Honda K; Ono M; Sekine S; Tanaka Y; Kobayashi M; Jung G; Sakuma T; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Tsuchida A; Shimahara M; Yasunami Y; Chiba T; Yamada T
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2195-203. PubMed ID: 21828233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
    Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
    Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
    Murakoshi Y; Honda K; Sasazuki S; Ono M; Negishi A; Matsubara J; Sakuma T; Kuwabara H; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Shimahara M; Yasunami Y; Ino Y; Tsuchida A; Aoki T; Tsugane S; Yamada T
    Cancer Sci; 2011 Mar; 102(3):630-8. PubMed ID: 21199170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.
    Ritter SY; Collins J; Krastins B; Sarracino D; Lopez M; Losina E; Aliprantis AO
    Arthritis Res Ther; 2014 Oct; 16(5):456. PubMed ID: 25287745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin in stool: a new biomarker for colon cancer screening?
    Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
    Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling reveals α1-antitrypsin, α1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women.
    Hsu TY; Hsieh TT; Yang KD; Tsai CC; Ou CY; Cheng BH; Wong YH; Hung HN; Chou AK; Hsiao CC; Lin H
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):499-504. PubMed ID: 26522099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.
    Chen H; Zucknick M; Werner S; Knebel P; Brenner H
    Clin Cancer Res; 2015 Jul; 21(14):3318-26. PubMed ID: 26015516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
    J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low folate levels are associated with reduced risk of colorectal cancer in a population with low folate status.
    Gylling B; Van Guelpen B; Schneede J; Hultdin J; Ueland PM; Hallmans G; Johansson I; Palmqvist R
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2136-44. PubMed ID: 25063522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of serum clusterin isoforms in colorectal cancer.
    Rodríguez-Piñeiro AM; de la Cadena MP; López-Saco A; Rodríguez-Berrocal FJ
    Mol Cell Proteomics; 2006 Sep; 5(9):1647-57. PubMed ID: 16854844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.